Pharmacoeconomic evaluation of simulect prophylaxis in renal transplant recipients

By Walters S.J.   Whitfield M.   Akehurst R.L.   Chilcott J.B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3187-3191

Elsevier

Access to resources Recommend Favorite

A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients

By Charpentier B.   European Tacrolimus vs Microemulsified Cyclosporin Study Group  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1625-1626

Elsevier

Access to resources Recommend Favorite

High risk kidney transplant rejection treatment: cost savings from thymoglobulin

By Schnitzler M.A.   Woodward R.S.   Lowell J.A.   Singer G.G.   Brennan D.C.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 269-271

Elsevier

Access to resources Recommend Favorite

Early experience with simulect (basiliximab) induction in living donor renal allografting in India

By Siwach V.   Dhanda R.   Aggarwal B.   Singh B.   Jain P.K.   Sarin P.K.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 196-197

Elsevier

Access to resources Recommend Favorite

Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids

By Lebranchu Y.   Aubert P.   Bayle F.   Bedrossian J.   Berthoux F.   Bourbigot B.   Buchler M.   Chalopin J.M.   Deteix P.   Glotz D.   Huraut De Ligny B.   Kessler M.   Lang P.   Lefrancois N.   Le Pogamp P.   Moulin B.   Mourad G.   Olmer M.   Sraer J.D.   Touchard G.   Toupance O.   Wolf P.   Puget S.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 396-397

Elsevier

Access to resources Recommend Favorite